Search hospitals > Illinois > Yorkville
Rush-Copley Healthcare Center
Claim this profileYorkville, Illinois 60560
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
213 reported clinical trials
13 medical researchers
Summary
Rush-Copley Healthcare Center is a medical facility located in Yorkville, Illinois. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Rush-Copley Healthcare Center is involved with conducting 213 clinical trials across 430 conditions. There are 13 research doctors associated with this hospital, such as Vamsi K. Vasireddy, Maria T. Grosse-Perdekamp, Suparna Mantha, and Kendrith Rowland, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Vamsi K. VasireddyCarle Cancer Center2 years of reported clinical research
Expert in Cancer
Studies Tumors
31 reported clinical trials
56 drugs studied
Maria T. Grosse-PerdekampCarle Cancer Center2 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
29 reported clinical trials
60 drugs studied
Suparna ManthaCarle Cancer Center4 years of reported clinical research
Studies Cancer
Studies Adenocarcinoma
34 reported clinical trials
77 drugs studied
Kendrith Rowland, MDCarle Cancer Center2 years of reported clinical research
Expert in Cancer
Studies Breast Cancer
30 reported clinical trials
61 drugs studied
Clinical Trials running at Rush-Copley Healthcare Center
Breast Cancer
Non-Small Cell Lung Cancer
Cancer
Lung Cancer
Bladder Cancer
Bladder Carcinoma
Melanoma
Squamous Cell Carcinoma
Cutaneous Melanoma
Gastric Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Rush-Copley Healthcare Center?
Rush-Copley Healthcare Center is a medical facility located in Yorkville, Illinois. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Rush-Copley Healthcare Center is involved with conducting 213 clinical trials across 430 conditions. There are 13 research doctors associated with this hospital, such as Vamsi K. Vasireddy, Maria T. Grosse-Perdekamp, Suparna Mantha, and Kendrith Rowland, MD.